The accelerated path of ceritinib: Translating pre-clinical development into clinical efficacy. (Record no. 27097888)

MARC details
000 -LEADER
fixed length control field 01600 a2200445 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250517151247.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201708s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1532-1967
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1016/j.ctrv.2017.03.006
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Mok, Tony S K
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20170809
245 00 - TITLE STATEMENT
Title The accelerated path of ceritinib: Translating pre-clinical development into clinical efficacy.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Cancer treatment reviews
Date of publication, distribution, etc. Apr 2017
300 ## - PHYSICAL DESCRIPTION
Extent 181-189 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article; Review
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aminopyridines
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Anaplastic Lymphoma Kinase
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Agents
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Carbazoles
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Carcinoma, Non-Small-Cell Lung
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Lactams
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Lactams, Macrocyclic
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Lung Neoplasms
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Organophosphorus Compounds
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Piperidines
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pyrazoles
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pyrimidines
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Receptor Protein-Tyrosine Kinases
General subdivision antagonists & inhibitors
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Sulfones
General subdivision adverse effects
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Crino, Lucio
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Felip, Enriqueta
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Salgia, Ravi
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name De Pas, Tommaso
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Tan, Daniel S W
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Chow, Laura Q M
773 0# - HOST ITEM ENTRY
Title Cancer treatment reviews
Related parts vol. 55
-- p. 181-189
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1016/j.ctrv.2017.03.006">https://doi.org/10.1016/j.ctrv.2017.03.006</a>
Public note Available from publisher's website

No items available.